1
|
Mahévas T, Osio A, Larcher L, Clappier E, Kempf W, Adès L, Fenaux P, Sébert M, Delaleu J, Jachiet M, Cordoliani F, Charvet E, Carpentier O, Itzykson RA, Weinborn M, Mardare N, Marco-Bonnet J, de Masson A, Duployez N, Huynh T, Bouaziz JD, Vignon-Pennamen MD, Battistella M. Cutaneous clonal mature plasmacytoid dendritic cell dermatosis in patients with myeloid neoplasms. Blood Adv 2024:bloodadvances.2023012489. [PMID: 38621250 DOI: 10.1182/bloodadvances.2023012489] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/21/2023] [Revised: 02/27/2024] [Accepted: 03/04/2024] [Indexed: 04/17/2024] Open
Affiliation(s)
- Thibault Mahévas
- Service de Dermatologie, Hôpital Saint-Louis, Paris, Paris, France
| | | | - Lise Larcher
- Service d'hématologie biologique, Hôpital Saint-Louis AP-HP, Paris ; France 4 Université Paris Cité, Génomes, biologie cellulaire et thérapeutique U944, INSERM, CNRS, F-75010 Paris, France, France
| | - Emmanuelle Clappier
- Service d'hématologie biologique, Hôpital Saint-Louis AP-HP, Paris ; France 4 Université Paris Cité, Génomes, biologie cellulaire et thérapeutique U944, INSERM, CNRS, F-75010 Paris, France, France
| | - Werner Kempf
- Kempf und Pfaltz Histologische Diagnostik, Zurich, Switzerland
| | | | | | | | | | | | | | - Estelle Charvet
- Service de Dermatologie, APHP, Hôpital Saint-Louis, Paris, Paris, France
| | | | | | - Marie Weinborn
- Laboratoire d'anatomie et cytologie pathologique, C .H. de Valenciennes, Valenciennes, France, Valenciennes, France
| | | | | | | | | | - Tony Huynh
- Hopital Saint-Louis, Universite de Paris-Cite, Paris, France
| | | | | | | |
Collapse
|
2
|
Fléchon L, Arib I, Dutta AK, Hasan Bou Issa L, Sklavenitis-Pistofidis R, Tilmont R, Stewart C, Dubois R, Poulain S, Copin MC, Javed S, Nudel M, Cavalieri D, Escure G, Gower N, Chauvet P, Gazeau N, Saade C, Thiam MB, Ouelkite-Oumouchal A, Gaggero S, Cailliau É, Faiz S, Carpentier O, Duployez N, Idziorek TB, Mortier L, Figeac M, Preudhomme C, Quesnel B, Mitra S, Morschhauser F, Getz G, Ghobrial IM, Manier S. Genomic profiling of Mycosis Fungoides identifies patients at high risk of disease progression. Blood Adv 2024:bloodadvances.2023012125. [PMID: 38513135 DOI: 10.1182/bloodadvances.2023012125] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/12/2023] [Revised: 02/15/2024] [Accepted: 02/17/2024] [Indexed: 03/23/2024] Open
Abstract
Mycosis fungoides (MF) is the most prevalent primary cutaneous T-cell lymphoma, with an indolent or aggressive course and poor survival. The pathogenesis of MF remains unclear, and prognostic factors in the early stages are not well-established. Here, we characterized the most recurrent genomic alterations using whole-exome sequencing of 67 samples from 48 patients from Lille University Hospital (France), including 18 sequential samples drawn across stages of the malignancy. Genomic data were analyzed on the Broad Institute's Terra bioinformatics platform. We found that gain7q, gain10p15.1 (IL2RA and IL15RA), del10p11.22 (ZEB1), or mutations in JUNB and TET2 are associated with high-risk disease stages. Furthermore, gain7q, gain10p15.1 (IL2RA and IL15RA), del10p11.22 (ZEB1), and del6q16.3 (TNFAIP3) are coupled with shorter survival. Del6q16.3 (TNFAIP3) was a risk factor for progression in low-risk patients. By analyzing the clonal heterogeneity and the clonal evolution of the cohort, we defined different phylogenetic pathways of the disease with acquisition of JUNB, gain10p15.1 (IL2RA and IL15RA), or del12p13.1 (CDKN1B) at progression. These results establish the genomics and clonality of MF and identify potential patients at risk of progression, independent of their clinical stage.
Collapse
Affiliation(s)
- Léa Fléchon
- Canther, INSERM UMR-S1277, CNRS UMR9020, Lille University, Lille, France
| | - Inès Arib
- Canther, INSERM UMR-S1277, CNRS UMR9020, Lille University, Lille, France
| | - Ankit K Dutta
- Dana-Farber Cancer Institute, Boston, Massachusetts, United States
| | | | | | | | - Chip Stewart
- Broad Institute, Cambridge, Massachusetts, United States
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | - Suman Mitra
- UMR 9020-UMR-S 1277-Canther, Institut de Recherche contre le Cancer de Lille, University Lille, CNRS, Inserm, CHU Lille, F-59000 Lille, France, Lille, France
| | | | - Gad Getz
- Broad Institute, Mass General Hospital, Cambridge, Massachusetts, United States
| | - Irene M Ghobrial
- Dana-Farber Cancer Institute, Boston, Massachusetts, United States
| | - Salomon Manier
- Canther, INSERM UMR-S1277, CNRS UMR9020, Lille University, Lille, France
| |
Collapse
|
3
|
Toulemonde E, Faiz S, Dubois R, Verhasselt-Crinquette M, Carpentier O, Abi Rached H, Mortier L. Photodynamic therapy for the treatment of primary cutaneous B-cell marginal zone lymphoma: A series of 4 patients. JAAD Case Rep 2023; 33:62-66. [PMID: 36860806 PMCID: PMC9969199 DOI: 10.1016/j.jdcr.2022.12.020] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/26/2023] Open
Affiliation(s)
- Elise Toulemonde
- Department of Dermatology, Claude Huriez Hospital, Lille University Hospital, Lille, France,Correspondence to: Elise Toulemonde, BA, 2 Ave Oscar Lambret, 59000, Lille, France.
| | - Sarah Faiz
- Department of Dermatology, Claude Huriez Hospital, Lille University Hospital, Lille, France,Department of Dermatology, Hospital of Douai, Douai, France
| | - Romain Dubois
- Department of Anatomopathology, Biology and Pathology Center Pierre-Marie Degand, CHU Lille, Lille, France
| | | | - Olivier Carpentier
- Department of Dermatology, Claude Huriez Hospital, Lille University Hospital, Lille, France,Department of Dermatology, Hospital of Roubaix, Roubaix, France
| | - Henry Abi Rached
- Department of Dermatology, Claude Huriez Hospital, Lille University Hospital, Lille, France
| | - Laurent Mortier
- Department of Dermatology, Claude Huriez Hospital, CARADERM and University of Lille, U1189 Inserm, Lille, France
| |
Collapse
|
4
|
Toulemonde E, Douxami M, Faiz S, Dubois R, Verhasselt-Crinquette M, Carpentier O, Abi Rached H, Mortier L. Efficacy of textile photodynamic therapy for mycosis fungoides. JAAD Case Rep 2022; 32:11-14. [PMID: 36620497 PMCID: PMC9813480 DOI: 10.1016/j.jdcr.2022.11.009] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
Affiliation(s)
- Elise Toulemonde
- Department of Dermatology, Claude Huriez Hospital, Lille University Hospital, Lille, France,Correspondence and reprint requests to: Elise Toulemonde, BA, Department of Dermatology, CHRU de Lille: Centre Hospitalier Universitaire de Lille, 2 avenue Oscar Lambret, 59000, Lille, France.
| | - Marion Douxami
- Department of Dermatology, Claude Huriez Hospital, Lille University Hospital, Lille, France
| | - Sarah Faiz
- Department of Dermatology, Claude Huriez Hospital, Lille University Hospital, Lille, France,Department of Dermatology, Hospital of Douai, Douai, France
| | - Romain Dubois
- Department of Anatomopathology, Biology and Pathology Center Pierre-Marie Degand, CHU Lille, Lille, France
| | | | - Olivier Carpentier
- Department of Dermatology, Claude Huriez Hospital, Lille University Hospital, Lille, France,Department of Dermatology, Hospital of Roubaix, Roubaix, France
| | - Henry Abi Rached
- Department of Dermatology, Claude Huriez Hospital, Lille University Hospital, Lille, France
| | - Laurent Mortier
- Department of Dermatology, Claude Huriez Hospital, CARADERM and University of Lille, Lille, France
| |
Collapse
|
5
|
Welfringer-Morin A, Barroil M, Fraitag S, Szablewski V, Boccara O, Lacour JP, Chiaverini C, Bagot M, Ram-Wolff C, Vignon-Pennamen MD, Dalle S, D'incan M, Amatore F, Beylot-Barry M, Vergier B, Mazereeuw-Hautier J, Tedbirt B, Quereux G, Carpentier O, Skowron F, Bertrand Y, Van Eeckhout P, Dekeuleneer V, Nardin C, Adamski H, Ingen-Housz-Oro S, Dereure O, Bodemer C. Clinical Features, Histological Characteristics, and Disease Outcomes of Mycosis Fungoides in Children and Adolescents: A Nationwide Multicentre Cohort of 46 Patients. Dermatology 2022; 239:132-139. [PMID: 36349768 DOI: 10.1159/000526788] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/02/2022] [Accepted: 06/21/2022] [Indexed: 11/06/2022] Open
Abstract
BACKGROUND Our objective was to describe the clinical, histological characteristics, and disease outcome of a cohort of mycosis fungoides (MF) diagnosed during childhood including disease status at adulthood. METHODS This is a retrospective multicentre survey of patients aged under 18 years at diagnosis with histologically confirmed MF. Patients' clinical and histological characteristics, treatments, and disease outcome (for patients followed for more than 12 months) were analysed. RESULTS Forty-six patients were included (median age at diagnosis: 11 years; M:F sex ratio: 3:1) with 39 (85%) followed for at least 12 months. Thirty-nine patients (85%) had stage I MF. Hypopigmented patches were observed in 48% and folliculotropism in 43% patients. Immunophenotype of the skin infiltrate was predominantly CD8+ in 17% of patients. Initial management included a wait-and-see strategy in 6/39 (15%), skin-directed treatment in 27 (69%), and systemic treatment in 6 (15%) patients, respectively, with partial or complete clinical response (PR or CR) observed in 28 patients (72%). 14/39 patients (36%) relapsed after initial response. After a median follow-up period of 54 months, disease status at last news was PR or CR in 31/39 (79%), stable disease in 6 (15%), and progression in 2 (5%) patients. Histological transformation was observed in 3/39 (8%). Of the 15 patients followed until adulthood, 13 (87%) had persistent MF. DISCUSSION This survey confirms the high frequency of hypopigmented and folliculotropic lesions and of CD8+ immunophenotype compared to adult MF patients. The long-term course is usually indolent but transformation may occur sometimes long after disease onset and the disease may persist during adulthood.
Collapse
Affiliation(s)
- Anne Welfringer-Morin
- Department of Dermatology, Hospital Necker-Enfants Malades, APHP. Centre-Université de Paris, Paris, France,
| | - Marion Barroil
- Department of Dermatology, University of Montpellier and INSERM U1058, Montpellier, France
| | - Sylvie Fraitag
- Department of Pathology, Hospital Necker-Enfants Malades, APHP. Centre-Université de Paris, Paris, France
| | | | - Olivia Boccara
- Department of Dermatology, Hospital Necker-Enfants Malades, APHP. Centre-Université de Paris, Paris, France
| | - Jean-Philippe Lacour
- Department of Dermatology, CHU de Nice, Université Nice Côte d'Azur, Nice, France
| | - Christine Chiaverini
- Department of Dermatology, CHU de Nice, Université Nice Côte d'Azur, Nice, France
| | - Martine Bagot
- Department of Dermatology, Hospital Saint Louis, APHP. Université de Paris, INSERM UMR 976, Paris, France
| | - Caroline Ram-Wolff
- Department of Dermatology, Hospital Saint Louis, APHP. Université de Paris, INSERM UMR 976, Paris, France
| | | | - Stéphane Dalle
- Department of Dermatology, Hospices Civils de Lyon, Hôpital Lyon Sud, Pierre Bénite, France
| | - Michel D'incan
- Department of Dermatology, CHU de Clermont-Ferrand, Clermont-Ferrand, France
| | - Florent Amatore
- Department of Dermatology, Hospital la Timone, Université Aix-Marseille, Assistance Publique des Hôpitaux de Marseille, Marseille, France
| | - Marie Beylot-Barry
- Department of Dermatology, CHU de Bordeaux, INSERM U1053 Oncogenèse des lymphomes cutanés, Université de Bordeaux, Bordeaux, France
| | - Béatrice Vergier
- Department of Pathology, CHU de Bordeaux, INSERM U1053 Oncogenèse des lymphomes cutanés, Université de Bordeaux, Bordeaux, France
| | | | | | - Gaelle Quereux
- Department of Dermatology, Hotel Dieu, CHU de Nantes, Nantes, France
| | - Olivier Carpentier
- Department of Dermatology, Hospital Claude Huriez, CHRU Lille, Lille, France
| | | | - Yves Bertrand
- Department of Hematology, Institut d'hématologie et oncologie pediatrique, Lyon, France
| | - Pascal Van Eeckhout
- Department of Pathology, Cliniques Universitaires Saint-Luc, Brussels, Belgium
| | - Valérie Dekeuleneer
- Department of Dermatology, Cliniques Universitaires Saint-Luc, Brussels, Belgium
| | - Charlee Nardin
- Department of Dermatology, CHU de Besancon, INSERM UMR 1098, Université de Franche-Comté, Besancon, France
| | - Henri Adamski
- Department of Dermatology, CHU Pontchaillou, Rennes, France
| | - Saskia Ingen-Housz-Oro
- Department of Dermatology, Hospital Henri Mondor, APHP, University Paris Est Créteil EpiDermE, Creteil, France
| | - Olivier Dereure
- Department of Dermatology, University of Montpellier and INSERM U1058, Montpellier, France
| | - Christine Bodemer
- Department of Dermatology, Hospital Necker-Enfants Malades, APHP. Centre-Université de Paris, Paris, France
| |
Collapse
|
6
|
Leblais C, Le Guern A, Bataille M, Quinchon JF, Carpentier O, Modiano P. Reticular erythematous mucinosis: A retrospective study of 13 patients. Ann Dermatol Venereol 2022; 149:185-188. [PMID: 35717250 DOI: 10.1016/j.annder.2022.01.011] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/03/2021] [Revised: 01/04/2022] [Accepted: 01/21/2022] [Indexed: 10/18/2022]
Affiliation(s)
- C Leblais
- Catholic University of Lille, Dermatology, 59800 Lille, France.
| | - A Le Guern
- Catholic University of Lille, Dermatology, 59800 Lille, France
| | - M Bataille
- Catholic University of Lille, Dermatology, 59800 Lille, France
| | - J-F Quinchon
- Catholic University of Lille, Pathology, 59800 Lille, France
| | - O Carpentier
- University Hospital Center of Lille, Dermatology, 59000 Lille, France
| | - P Modiano
- Catholic University of Lille, Dermatology, 59800 Lille, France
| |
Collapse
|
7
|
D'Mello Y, Bernal S, Helmy A, Berikaa E, Carpentier O, Alamgir I, Alam MS, El-Fiky E, Plant DV. Standalone, CMOS-based Faraday rotation in a silicon photonic waveguide. Opt Express 2022; 30:24602-24610. [PMID: 36237011 DOI: 10.1364/oe.453840] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/06/2022] [Accepted: 05/25/2022] [Indexed: 06/16/2023]
Abstract
Nonreciprocity is a fundamental requirement of signal isolation in optical communication systems. However, on chip isolator designs require either post-processing steps or external magnetic biasing, which are impractical for commercial applications. This raises the need for standalone devices which support nonreciprocal functionality using standardized fabrication techniques. Here, we report the first design of an electromagnetic coil surrounding a waveguide which exclusively employed the complementary metal-oxide-semiconductor (CMOS) process flow. The coil supported an electric current up to 14 mA. In simulations, it generated an alternating magnetic flux density up to 1.16 mT inside a strip waveguide and thereby induced a rotation of 50.71 picodegrees for the fundamental transverse-magnetic mode at a wavelength of 1352 nm. Our analysis further revealed methods to increase the rotation by orders of magnitude. It demonstrated the scope of manufacturing processes and serves as a building block for the development of a commercially viable, on-chip optical isolator.
Collapse
|
8
|
Petersen T, Mahévas T, Cannet P, Bouaziz JD, Hua C, Zarnitsky C, Modiano P, Lifermann F, Sassolas B, Carpentier O, Mékinian A, Garderet L, Aucouturier P, Chantran Y. IgG1 Subclass Restriction and Biochemical Peculiarities of Monoclonal Immunoglobulins in Scleromyxedema. Clin Lab 2021; 67. [PMID: 33739037 DOI: 10.7754/clin.lab.2020.200605] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
Abstract
BACKGROUND Scleromyxedema (SME) is a rare mucinosis associated with monoclonal gammopathy. Several biochemical peculiarities of monoclonal immunoglobulins (Ig) in SME patients were reported in case reports or short series, such as IgGλ over-representation, cationic migration, and partial deletion. METHODS Monoclonal immunoglobulins (Ig) from the serum of 12 consecutive patients diagnosed with scleromyxedema (SME) were analyzed using electrophoretic and immunoblotting techniques. RESULTS All monoclonal Ig from 12 SME were of IgG1 subclass, with an overrepresentation of the lambda-type light chain and a cationic mobility on standard zone electrophoresis, as compared with 21 cases of monoclonal gammopathy of undetermined significance (MGUS) of IgG1 subclass. Reactivity with specific monoclonal antibodies demonstrated no evident deletion of the heavy chain constant domains, which was also confirmed by analysis of Ig heavy chain molecular weight on a purified monoclonal component from one case. CONCLUSIONS Significant isotype restriction of both heavy and light chains, and peculiar biochemical properties suggest that monoclonal Ig might be involved in pathophysiological events of SME.
Collapse
|
9
|
Maanaoui S, Salez F, Carpentier O. Recurrence of chilblains during a second contact with SARS-CoV-2: a case report. Br J Dermatol 2021; 185:227-228. [PMID: 33733452 PMCID: PMC8251053 DOI: 10.1111/bjd.20070] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/12/2020] [Revised: 03/15/2021] [Accepted: 03/15/2021] [Indexed: 12/16/2022]
Affiliation(s)
- S Maanaoui
- Service de Dermatologie, Centre Hospitalier de Roubaix, Roubaix, F-59100, France
| | - F Salez
- Service de Pneumologie, Centre Hospitalier de Roubaix, F-59100, Roubaix, France
| | - O Carpentier
- Service de Dermatologie, Centre Hospitalier de Roubaix, Roubaix, F-59100, France
| |
Collapse
|
10
|
Jacques M, El-Fiky E, Xing Z, Samani A, Carpentier O, Plant DV. 23-dB average isolation using a silicon photonic Mach-Zehnder modulator. Opt Express 2020; 28:26056-26066. [PMID: 32906882 DOI: 10.1364/oe.392002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/04/2020] [Accepted: 08/13/2020] [Indexed: 06/11/2023]
Abstract
We demonstrate an optical time-gate isolator entirely fabricated on the silicon-on-insulator (SOI) platform based on a conventional traveling-wave Mach-Zehnder modulator (TW-MZM) design. The device achieves 18.2 dB (22.7 dB) time-averaged isolation when driven with 2.0-Vpp (7.1-Vpp) differential clock signals at 6.8 GHz and biased at null. Under these conditions, the isolator blocks backward light at all time regardless of driver amplitude, but produces periodic modulation in the forward direction. Moreover, we embed our isolator in a digital communication link and measure a signal-to-noise ratio (SNR) penalty of only 0.5 dB due to the isolator at 13.6 Gbaud PAM-4 data rate. Our device can be integrated in larger circuits to protect laser sources or mitigate interference.
Collapse
|
11
|
Stien S, Durot E, Durlach A, Beylot-Barry M, Adamski H, Beltraminelli H, Bohelay G, Carlotti A, Carpentier O, Cornillet P, Dubois R, Franck N, Husson B, Laroche L, Maubec E, le Clech C, Machet L, Ortonne N, Ram-Wolff C, Vergier B, Grange F. Cutaneous Involvement in Waldenström's Macroglobulinaemia. Acta Derm Venereol 2020; 100:adv00225. [PMID: 32488284 PMCID: PMC9207641 DOI: 10.2340/00015555-3535] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022] Open
Abstract
Cutaneous involvement in Waldenström’s macroglobulinaemia (WM) has been poorly characterized. To describe this involvement, a retrospective study of 19 patients with WM and cutaneous involvement of tumour B cells was performed. Twelve patients (group 1) had lymphoplasmacytic, non-transformed cutaneous proliferation, while in 7 cases (group 2) cutaneous involvement corresponded to histological transformation. In group 1, skin involvement was inaugural in 6 cases. The lesions were infiltrated plaques (83%), papules (25%) and tumours (42%). Four patients had a similar clinical picture (purplish, bilateral and symmetrical infiltration on the face). MYD88 L265P mutation was detected in the skin biopsy in all 6 cases tested. The 3-year specific survival rate was 88%. In group 2, cutaneous transformation occurred during the followup of the WM (71%). Lesions presented as ulcerated tumours (86%) of the trunk (57%) and lower limbs (57%). The 3-year specific survival rate was 22%. Skin involvement in WM has distinctive characteristics (e.g. clinical, histological, immunohistochemical, MYD88 L265P mutation).
Collapse
Affiliation(s)
- Sarah Stien
- Department of Oncodermatology, Robert Debré Hospital, avenue du Général Koenig, FR-51092 Reims Cedex, France. E-mail:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
12
|
Sonigo G, Battistella M, Beylot-Barry M, Oro S, Franck N, Barete S, Boulinguez S, Dereure O, Bonnet N, Socié G, Brice P, Boccara O, Bodemer C, Adamski H, D’Incan M, Ortonne N, Fraitag S, Brunet-Possenti F, Dalle S, Suarez F, Marcais A, Skowron F, Haidar D, Maubec E, Bohelay G, Laroche L, Mahé A, Birckel E, Bouaziz JD, Brocheriou I, Dubois R, Faiz S, Fadlallah J, Ram-Wolff C, Carlotti A, Bens G, Balme B, Vergier B, Laurent-Roussel S, Deschamps L, Carpentier O, Moguelet P, Hervé G, Comoz F, Le Gall F, Leverger G, Finon A, Augereau O, Bléchet C, Kerdraon R, lamant L, Tournier E, Franck F, Costes-Martineau V, Szablewski V, Taix S, Beschet I, Guérin F, Sepulveda F, Bagot M, De Saint-Basile G, Michonneau D, De Masson A. Étude clinique à long terme et mutations HAVCR2 chez 70 patients atteints de lymphome T sous cutané à type de panniculite. Ann Dermatol Venereol 2019. [DOI: 10.1016/j.annder.2019.09.144] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
13
|
Dubois M, Faiz S, Vicentini C, Carpentier O, Mortier L. Réaction locale au rituximab. Ann Dermatol Venereol 2019. [DOI: 10.1016/j.annder.2019.09.427] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
14
|
Faiz S, Carpentier O, Forcade E, Beylot-Barry M, Yakoub Agha I, Fegueux N, Dereure O, Goursaud L, Chevalier P, Huynh A, Rubio MT, Granata A, Charbonnier A, Dulery R, Suarez F, Bay JO, Bagot M, De Masson A, Pefault De Latour R, Magro L, Mortier L. Réinjections de lymphocytes du donneur dans les lymphomes cutanés T : une cohorte rétrospective multicentrique française pour la SFGM-TC et le GFLEC. Ann Dermatol Venereol 2018. [DOI: 10.1016/j.annder.2018.09.069] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
15
|
Béné J, Carpentier O, Sabanowski S, Laroche ML, Beyens MN, Lambert M, Gautier S. Nicorandil and cutaneous ulcerations, their misdiagnosis and consequences: Illustration by five cases reports and a review of the French pharmacovigilance database. Therapie 2018; 73:409-417. [DOI: 10.1016/j.therap.2018.01.004] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/05/2017] [Accepted: 01/16/2018] [Indexed: 12/01/2022]
|
16
|
Faiz S, Duvert-Lehembre S, Levavasseur M, Srour M, Pignon JM, Bouchindhomme B, Carpentier O, Mortier L. Lésion de la pointe du nez révélant une tumeur blastique à cellules dendritiques plasmacytoïdes. Ann Dermatol Venereol 2017. [DOI: 10.1016/j.annder.2017.09.444] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
17
|
Mahevas T, Jachiet M, Servy A, Livideanu CB, Cribier B, Frances C, Le Moigne M, Sbidian E, Bouaziz JD, Descamps V, D’incan M, Humbert P, Beylot-Barry M, Passeron T, Arnulf B, Harel S, Sassolas B, de Moreuil C, Hermine O, Dupuy A, Barbarot S, Debardieux S, Carpentier O, Brault F, Schmutz JL, Thomas-Beaulieu D, Zarnitsky C, Limal N, Le-Bras F, Osio A, Battistella M, Tauber M, Mékinian A, Fain O. Caractéristiques clinicobiologiques, facteurs pronostiques et prise en charge thérapeutique du scléromyxœdème : étude rétrospective multicentrique. Ann Dermatol Venereol 2017. [DOI: 10.1016/j.annder.2017.09.157] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
18
|
Farman B, Carpentier O, Bourrelly M, Taieb D. 21A. Radiation protection of the patients’ entourage treated for hyperthyroidism with radioiodine. Phys Med 2016. [DOI: 10.1016/j.ejmp.2016.11.072] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/25/2022] Open
|
19
|
Faiz S, Magro L, Desmedt E, Herbaux C, Carpentier O, Mortier L. Réinjection de lymphocytes du donneur après allogreffe pour un mycosis fongoïde réfractaire. Ann Dermatol Venereol 2016. [DOI: 10.1016/j.annder.2016.09.550] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
20
|
Carpentier O, Selvaggi L, Jégu J, Purohit A, Prim N, Velten M, Quoix E. Modern Treatments in Advanced Non-Small-Cell Lung Cancer: Temporal Trends and Effect on Survival. A French Population-Based Study. Clin Lung Cancer 2015; 16:496-506. [PMID: 26071190 DOI: 10.1016/j.cllc.2015.05.001] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/26/2015] [Revised: 04/28/2015] [Accepted: 05/05/2015] [Indexed: 12/12/2022]
Abstract
UNLABELLED Extrapolation of clinical trials results to the general population is always challenging. We analysed 1047 patients diagnosed with an advanced stage disease between 1998 and 2005 in a french administrative department and found a good spread of modern chemotherapy since 1998 and targeted therapy since 2002. Moreover, the outcomes in patients treated according to guidelines are very proximal from those obtained in clinical trials. BACKGROUND Management of metastatic non-small-cell lung cancer has considerably evolved during the past 2 decades. In this study we aimed to assess how treatments have spread at a population-based level and their effect on survival. PATIENTS AND METHODS Medical records of patients diagnosed from 1998 to 2005 in the French department of Bas-Rhin were checked to collect data on patient characteristics and treatments received. Multivariate analysis of survival was performed using pretherapeutic and therapeutic factors including targeted therapies received as third-line treatment. RESULTS We included 1047 patients with stage IIIB to IV non-small-cell lung cancer. The proportion of patients who underwent chemotherapy increased from 373/471 (79.2%) to 491/576 (85.2%) over the 1998 to 2001 and 2002 to 2005 periods, and there was an increased use of third-generation drugs associated with platin. Third-line treatment was gefitinib or erlotinib in 73/155 (47.1%) of the cases among patients diagnosed from 2002 to 2005. Compared with older agents, targeted therapy administered as third-line treatment was associated with a longer survival but there was no significant difference in survival with recent chemotherapy agents in multivariate analyses (hazard ratio, 0.773; 95% confidence interval, 0.445-1.343). CONCLUSION Results of our study showed a good spread of modern chemotherapy and targeted therapy use at a population-based level. However, even if the general outcomes were improved along the years, the results observed in real clinical practice were slightly different from those reported in clinical trials.
Collapse
Affiliation(s)
- Olivier Carpentier
- Laboratoire d'épidémiologie et de santé publique, EA3430, Faculté de Médecine, Université de Strasbourg, Strasbourg, France
| | - Lucia Selvaggi
- Service de pneumologie, Nouvel Hôpital Civil, Strasbourg, France
| | - Jérémie Jégu
- Laboratoire d'épidémiologie et de santé publique, EA3430, Faculté de Médecine, Université de Strasbourg, Strasbourg, France; Service de santé publique, Nouvel Hôpital Civil, Strasbourg, France
| | - Ashok Purohit
- Service de pneumologie, Nouvel Hôpital Civil, Strasbourg, France
| | - Nathalie Prim
- Service de pneumologie, Nouvel Hôpital Civil, Strasbourg, France
| | - Michel Velten
- Laboratoire d'épidémiologie et de santé publique, EA3430, Faculté de Médecine, Université de Strasbourg, Strasbourg, France; Service de santé publique, Nouvel Hôpital Civil, Strasbourg, France
| | - Elisabeth Quoix
- Service de pneumologie, Nouvel Hôpital Civil, Strasbourg, France.
| |
Collapse
|
21
|
Ister M, Pouessel G, Ythier H, Catteau B, Carpentier O. Postvaccinal, corticosteroid-resistant bullous pemphigoid in infancy: treatment with intravenous immunoglobulin. Pediatr Dermatol 2014; 31:e94-5. [PMID: 24916151 DOI: 10.1111/pde.12360] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/25/2022]
Abstract
Bullous pemphigoid is an autoimmune subepidermal blistering disorder that typically affects elderly adults but can also occur in childhood. We report on a 3-month-old boy who developed bullous pemphigoid 1 week after the second routine administration of a hexavalent vaccine. The disease was resistant to standard therapies (including oral and topical corticosteroids) but was relieved by intravenous immunoglobulin treatment. There was no recurrence of bullous pemphigoid after the next vaccination (3 mos after discontinuation of steroids).
Collapse
Affiliation(s)
- Marielle Ister
- Department of Pediatrics, Victor Provo Hospital, Roubaix, France
| | | | | | | | | |
Collapse
|
22
|
Carpentier O. Prise en charge et évolution des cancers bronchiques non à petites cellules de stades IIIB et IV dans le département français du Bas-Rhin de 1998 à 2005. Rev Epidemiol Sante Publique 2014. [DOI: 10.1016/j.respe.2013.12.006] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022] Open
|
23
|
Morizot G, Kendjo E, Mouri O, Thellier M, Pérignon A, Foulet F, Cordoliani F, Bourrat E, Laffitte E, Alcaraz I, Bodak N, Ravel C, Vray M, Grogl M, Mazier D, Caumes E, Lachaud L, Buffet PA, El Samad Y, Salle V, Gounod N, Dallot A, Belot G, Pelletier-Cunat S, Belon M, Verdon R, Rogeaux O, Grossetête G, Lesens O, Clabaut A, Maus E, Jouy L, Gener G, Perrin P, Roch N, Herve A, Le Duc D, Cuchet E, Maubon D, Hillion B, Menot E, Guillemot F, Beneton-Benhard N, Celerier P, Dupuis De Fonclare AL, Carre D, Bourgeois A, Marty P, Pomares C, Meunier L, Abergel H, Timsit F, Amoric JC, Busquet P, Karam S, Moisson YF, Mouly F, Ortoli JC, Consigny PH, Jouan M, Caby F, Datry A, Hochedez P, Rozembaum F, Dumortier C, Ancelle T, Dupin N, Paugam A, Ranque B, Bougnoux ME, Canestri A, Galezowsky MF, Hadj Rabia S, Hamel D, Schneider P, Wolter-Desfosses M, Janier M, Baccard M, Bezier M, Broissin M, Colin De Verdiere N, Durupt F, Hope Rapp E, Juillard C, Levy A, Moraillon I, Petit A, Regner S, Barthelme D, Tamarin JM, Begon E, Strady C, Gangneux JP, Carpentier O, Mechai F, Kieffer C, Dellestable P, Rebauder S. Travelers With Cutaneous Leishmaniasis Cured Without Systemic Therapy. Clin Infect Dis 2013; 57:370-80. [DOI: 10.1093/cid/cit269] [Citation(s) in RCA: 41] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Affiliation(s)
- G. Morizot
- Unité d'Immunologie Moléculaire des Parasites, Institut Pasteur de Paris
| | | | - O. Mouri
- Service de Parasitologie-Mycologie
| | | | - A. Pérignon
- Service de Maladies Infectieuses et Tropicales, Hôpital Pitié-Salpêtrière, Paris
| | - F. Foulet
- Service de Parasitologie-Mycologie, Hôpital Henri Mondor, Créteil
| | | | - E. Bourrat
- Service de Dermatologie, Hôpital Saint-Louis, Paris
- Service de Pédiatrie générale, Hôpital Robert Debré, Paris, France
| | - E. Laffitte
- Clinique de Dermatologie, Hôpitaux Universitaires de Genève, Switzerland
| | - I. Alcaraz
- Service de Maladies Infectieuses et Pathologie du voyageur, Hôpital Gustave Dron, Tourcoing
| | - N. Bodak
- Service de Dermatologie, Hôpital Necker, Paris
| | - C. Ravel
- French Reference Centre on Leishmaniasis, Montpellier
| | - M. Vray
- Unité de Recherche et d'Expertise Épidémiologie des Maladies Émergentes, Institut Pasteur de Paris/INSERM, France
| | - M. Grogl
- Walter Reed Army Institute of Research, Silver Spring, Maryland
| | | | - E. Caumes
- Service de Maladies Infectieuses et Tropicales, Hôpital Pitié-Salpêtrière, Paris
| | - L. Lachaud
- French Reference Centre on Leishmaniasis, Montpellier
| | - P. A. Buffet
- Unité d'Immunologie Moléculaire des Parasites, Institut Pasteur de Paris
- Service de Parasitologie-Mycologie
- UMRs 945 INSERM–Paris 6 University, France
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
24
|
Bécourt C, Pouessel G, Catteau B, Martin Delasalle E, Ythier H, Carpentier O. Pemphigoïde bulleuse cortico-résistante du nourrisson : efficacité des immunoglobulines. Ann Dermatol Venereol 2012. [DOI: 10.1016/j.annder.2012.10.172] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
25
|
Vonarx M, Carpentier O, Cazin B, Bouchindhomme B, Delaporte E. Leucémie lymphoïde chronique révélée par des infiltrats cutanés spécifiques en l’absence d’hyperlymphocytose : deux observations. Ann Dermatol Venereol 2012; 139:641-6. [DOI: 10.1016/j.annder.2012.06.040] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/24/2012] [Revised: 06/05/2012] [Accepted: 06/28/2012] [Indexed: 10/27/2022]
|
26
|
Chauchois A, Antczak E, Defer D, Carpentier O. Formalism of thermal waves applied to the characterization of materials thermal effusivity. Rev Sci Instrum 2011; 82:074902. [PMID: 21806216 DOI: 10.1063/1.3600899] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/31/2023]
Abstract
Thermal characterization of materials, especially civil engineering materials, in the way of non-destructive methods, are more and more widespread. In this article, we show an original point of view to describe the used method, the thermal waves, to obtain the thermal impedance of the studied system, using a specific sensor--a fluxmeter. The identification technique, based on a frequential approach, is optimized by applying a random input to the system. This kind of random heating is shown to provide a frequency range where the thermal effusivity is able to be identified and not correlated to another parameter. The strength of the method is also the determination of the contact resistance of the system, that allows to validate the identification process. Experimental results obtained from a sample with well-known thermal properties (polyvinyl chloride) are used to validate the proposed method.
Collapse
|
27
|
Just N, Carpentier O, Brzezinki C, Steenhouwer F, Staumont-Salle D. Severe hypersensitivity reaction as acute eosinophilic pneumonia and skin eruption induced by proguanil. Eur Respir J 2011; 37:1526-8. [DOI: 10.1183/09031936.00123710] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
|
28
|
Azarnoush S, Carpentier O, Thumerelle C, Flammarion S, Lambilliotte A, Botte A, Ythier H, Pouessel G. Histiocytose langerhansienne néonatale. Arch Pediatr 2010. [DOI: 10.1016/j.arcped.2010.08.028] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
29
|
Azarnoush S, Carpentier O, Thumerelle C, Flammarion S, Lambilliotte A, Botte A, Ythier H, Pouessel G. [Cutaneous eruption associated with respiratory distress in an infant. Neonatal Langerhans cell histiocytosis]. Arch Pediatr 2010; 17:1571-2, 1583-5. [PMID: 20884184 DOI: 10.1016/j.arcped.2010.08.027] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/17/2009] [Revised: 04/13/2010] [Accepted: 08/08/2010] [Indexed: 11/15/2022]
Affiliation(s)
- S Azarnoush
- Service de pédiatrie, pavillon de pédiatrie médicochirurgicale, centre hospitalier de Roubaix, 11-17, boulevard Lacordaire, BP 359, 59056 Roubaix, France
| | | | | | | | | | | | | | | |
Collapse
|
30
|
Maire C, Delesalle F, Carpentier O, Lequint P, Delaporte E, Thomas P. Carcinomes basocellulaires multiples après traitement d’un psoriasis par étanercept. Ann Dermatol Venereol 2009; 136:355-9. [DOI: 10.1016/j.annder.2008.10.036] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/29/2008] [Accepted: 10/10/2008] [Indexed: 12/20/2022]
|
31
|
Carpentier O, D’arrigo E, Ythier H, Giard H, Cixous E. SFP-P174 – Pathologie infectieuse – Une surprenante lésion cutanée saisonnière. Arch Pediatr 2008. [DOI: 10.1016/s0929-693x(08)72303-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
32
|
Morell-Dubois S, Carpentier O, Cottencin O, Queyrel V, Hachulla E, Hatron PY, Delaporte E. Stressful life events and pemphigus. Dermatology 2008; 216:104-8. [PMID: 18216471 DOI: 10.1159/000111506] [Citation(s) in RCA: 30] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/26/2007] [Accepted: 06/28/2007] [Indexed: 01/09/2023] Open
Abstract
BACKGROUND Stress might be a triggering factor causing pemphigus. We studied 11 consecutive cases of pemphigus over 5 years. OBJECTIVE Studying and looking for a link between severe life events and the history of the disease. METHODS An epidemiological retrospective and prospective study was carried out, including an interview and a collection of the clinical history; then the life events were integrated into the clinical history with the patient blind. Two scales were used: Paykel's inventory (assessing the negative impact of life events) and the Mini International Neuropsychiatric Interview DSM-IV (MINI). RESULTS 10 patients out of 11 were included. With the MINI, 2 patients presented anxiety. Paykel's inventory showed type 3 life events for numerous patients, life event type 4 for 7 patients and type 5 for 3 patients, happening from 1 to 6 months before the first signs or worsening of pemphigus. We found stressful life events before the start or worsening of pemphigus for all patients with no other risk factors. CONCLUSION Stressful life events can worsen or trigger off a pemphigus. Psychological care, associated with the immunosuppressive treatment, should entail a better management of these patients.
Collapse
Affiliation(s)
- S Morell-Dubois
- Internal Medicine Department, CHRU Lille and Lille II University, Lille, France.
| | | | | | | | | | | | | |
Collapse
|
33
|
Pouessel G, Ythier H, Carpentier O, Vachée A, Etienne J, Catteau B. Childhood pustular psoriasis associated with Panton-Valentine leukocidin-producing Staphylococcus aureus. Pediatr Dermatol 2007; 24:401-4. [PMID: 17845166 DOI: 10.1111/j.1525-1470.2007.00459.x] [Citation(s) in RCA: 16] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
We report the association of a generalized pustular psoriasis and infection by Staphylococcus aureus which produced Panton-Valentine leukocidin in a 5-year-old child. Another S. aureus strain with the same toxin gene content was also isolated among three family members presenting with cutaneous lesions. Although a methicillin-resistant staphylococcal strain has been reported in association with pustular psoriasis, this is the first report of a Panton-Valentine leukocidin strain associated with generalized pustular psoriasis. The causal relationship between S. aureus produced Panton-Valentine leukocidin and skin lesions is discussed.
Collapse
|
34
|
Puechguiral-Renaud I, Carpentier O, Piette F, Delaporte E. Subcorneal pustulosis and Pyoderma gangrenosum associated with a biclonal gammopathy. Eur J Dermatol 2006; 16:687-90. [PMID: 17229613] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 07/03/2006] [Indexed: 05/13/2023]
Abstract
Pyoderma gangrenosum and subcorneal pustulosis are two neutrophilic dermatoses. Their occurrence in the same patient is rare and may be related to an IgA dysglobulinemia. We report a case presenting these two conditions associated with a biclonal benign IgA and IgG gammopathy. A 67-year-old man exhibited typical pyoderma gangrenosum associated after three years duration with subcorneal pustulosis lesions, confirmed by cutaneous biopsy. Laboratory results showed a biclonal benign IgA and IgG kappa gammopathy. Therapeutic management was difficult: Pyoderma gangrenosum responded well to corticosteroids but subcorneal pustulosis management was harder and treatments were poorly effective.Pyoderma gangrenosum and subcorneal pustulosis are a part of the neutrophilic spectrum. Their association has been only reported in eleven patients. In eight cases, an IgA dysglobulinemia was associated suggesting its responsibility in the occurrence of both dermatoses. Treatments are various and not fully effective. If the Pyoderma gangrenosum usually responds to corticosteroids, the subcorneal pustulosis treatments are not well defined and often not efficient. Our case illustrates the dissociated evolution of these two dermatoses and their difficult global management. During the follow-up, a regular search for dysglobulinemia is required in order to detect malignant transformations.
Collapse
Affiliation(s)
- I Puechguiral-Renaud
- Clinique dermatologique, Hôpital Claude Huriez, Centre Hospitalier Universitaire, 1, rue Michel Polonowski, 59037 Lille Cedex, France
| | | | | | | |
Collapse
|
35
|
Darras-Vercambre S, Carpentier O, Vincent P, Bonnevalle A, Thomas P. Photodynamic action of red light for treatment of erythrasma: preliminary results. Photoderm Photoimm Photomed 2006; 22:153-6. [PMID: 16719870 DOI: 10.1111/j.1600-0781.2006.00211.x] [Citation(s) in RCA: 28] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/18/2022]
Abstract
BACKGROUND Erythrasma is a superficial cutaneous infection caused by Corynebacterium minutissimum and is characterized by fluorescence under Wood's light (UV) because of the presence of porphyrins. These molecules are photosensitizing and we propose to assess efficacy of red light that activates porphyrins (photodynamic reaction) in treatment of this pathology. OBJECTIVES Assessment of effects of photodynamic action of red light for treatment of erythrasma without exogenous photosensitizing molecules. METHODS Thirteen patients with erythrasma were treated by one illumination (80 J/cm2) by red light (broad band, peak at 635 nm) without exogenous photosensitizing molecules. Disappearance or reduction of extent of lesions were observed 2 weeks later. If lesions were still present, a second irradiation was conducted with the same method. RESULTS Preliminary results are presented. As a result of red light irradiation, we noticed a complete recovery for three patients and, in most other cases, reduction of extent of lesions (mean: -29% after one session). The treatment was well tolerated. CONCLUSION We report first cases of photodynamic treatment of erythrasma. There are other reports of clinical applications of antimicrobial action of photodynamic therapy in dermatology (acne vulgaris, leishmaniasis, warts, etc.). But there are few applications without addition of exogenous photosensitizing agent. The originality and interest of our study is to use spontaneous presence of porphyrins in the lesions. This technique seems to be an interesting alternative, inexpensive and easy, for the treatment of this localized infection. But an optimal method is still to be determined to improve efficacy.
Collapse
Affiliation(s)
- S Darras-Vercambre
- Clinique de Dermatologie, Hôpital Claude Huriez, CHRU, Lille Cedex, France
| | | | | | | | | |
Collapse
|
36
|
|
37
|
Casacci M, Carpentier O, Truffert P, Piette F, Catteau B. Exanthème maculo-papuleux néonatal révélateur d’une septicémie à Klebsiella pneumoniae par infection maternofœtale. Ann Dermatol Venereol 2006; 133:31-3. [PMID: 16495848 DOI: 10.1016/s0151-9638(06)70839-0] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
BACKGROUND Neonatal exanthema of bacterial origin is caused very rarely by Gram-negative bacilli. We report a case of neonatal maculopapular exanthema evocative of Klebsiella pneumoniae septicemia resulting from maternofetal infection. OBSERVATION On the fourth day of life, a newborn infant presented incipient morbilliform maculopapular exanthema on the face. During delivery, the mother had presented hyperthermia and meconium was found in the amniotic fluid. Clinical examination of the newborn was normal. No clinically obvious site of entry of infection was seen. Laboratory tests revealed major inflammatory syndrome. Blood cultures were positive for K. pneumoniae, which was also found in blood cultures from the mother. Screening for other causes of infection was negative. Parenteral antibiotics for 10 days yielded favorable results with simultaneous resolution of the exanthema, normalization of laboratory values and negative blood cultures. DISCUSSION Exanthemas of infectious origin are not associated with any specific organism. The most common causative micro-organisms are Listeria monocytogenes, B streptococci, colibacilli, and more rarely, staphylococci. There have been reports of a number of cases of neonatal septicemia due to Gram-negative bacilli responsible for maculopapular exanthemas but the causative organism was not identified. To our knowledge, Klebsiella pneumoniae has never been incriminated in the appearance of this type of rash via maternofetal transmission. Consequently, the presence of neonatal exanthema should prompt screening for sepsis, even in the absence of other evocative signs, and in particular in settings of apyrexia.
Collapse
Affiliation(s)
- M Casacci
- Clinique de Dermatologie, Hôpital Huriez, Lille
| | | | | | | | | |
Collapse
|
38
|
Carpentier O, Thomas P, Plantier F, Moyal Barocco M. P292 - Lichen scléreux vulvaire et thyroïdite auto-immune : pas d’association significative. Ann Dermatol Venereol 2005. [DOI: 10.1016/s0151-9638(05)80021-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/15/2022]
|
39
|
Delesalle F, Carpentier O, Gautier S, Delaporte E. Toxic epidermal necrolysis caused by tetrazepam. Int J Dermatol 2005. [DOI: 10.1111/j.1365-4632.2005.02654.x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
40
|
Abstract
INTRODUCTION Necrotic angiodermatitis is a variety of leg ulcer, characterized by very painful and rapidly spreading lesions. Healing takes time, a mean of 4 to 11 months. Current treatment is difficult and rarely satisfactory. Only early skin grafts lead to rapid sedation of pain and stop the lesion from extending. However, this technique, performed during a progressive phase, enhances the risk of losing a certain number of grafts. We wanted to confirm the efficacy of local auto-haemo-therapy proposed in 2 non-controlled studies. PATIENTS AND METHODS Eleven patients with necrotic angiodermatitis were included in our non-controlled prospective study. The topical hemotherapy was applied three times a week for one month, with initial hospitalization for 15 days. The criteria of assessment were: evolution of pain, surface of the ulcer, colorimetric scale and the date of disappearance of the purple halo. RESULTS Ten patients were relieved by the treatment, with progressive withdrawal of the analgesics. The progression of the lesion had stopped and the purple halo had disappeared in general by D6 (range: 2 to 21 days). The percentage of granulation tissue with regard to the surface of the ulcer was of 45.4 p. 100 on D0, 80 p. 100 on D14 and 85 p. 100 on D28. CONCLUSION Topical hemotherapy applied during the initial phase of treatment would reduce the pain and prepare the lesion for a secondary skin graft.
Collapse
Affiliation(s)
- D Courivaud
- Clinique Dermatologique, Hôpital Huriez, CHRU, 1, place de Verdun, 59000 Lille
| | | | | | | | | |
Collapse
|
41
|
Abstract
INTRODUCTION Primitive cutaneous neuroendocrine carcinoma or Merkel cell carcinoma is a tumor characterized by rapid evolution. The size at the time of diagnosis is a mean of 2 to 3 centimeters. We report a case of a particular clinical and anatomopathological presentation. OBSERVATION A 76 year-old woman had a voluminous tumoral plaque on the left leg with multiple ulcero-necrotic lesions involving the bone structure without palpable, inguinal lymphadenopathy. The histological and immunocytochemistry examination led to the diagnosis of cutaneous neuroendocrine carcinoma. The normality of the chest, abdominal and pelvis investigations confirmed the primitive cutaneous origin. The patient died a few months later without lymph involvement. DISCUSSION To the best of our knowledge, such a presentation of primitive cutaneous neuroendocrine carcinoma has never been reported. The absence of lymphadenopathy despite the tumor volume and extensive skin involvement suggest the hypothesis of a non lymphophilic form of primitive cutaneous neuroendocrine carcinoma. This case report shows that lymphophily depends neither on the tumoral size nor to the degree of differentiation of tumoral cell proliferation, but on biological factors that require specification.
Collapse
Affiliation(s)
- D Lebas
- Clinique Dermatologique, Hôpital Claude Huriez, Lille
| | | | | | | | | |
Collapse
|
42
|
Abstract
Juvenile xanthogranuloma is the most common non-Langerhans cell histiocytosis of infancy and childhood. It is a benign disorder that usually regresses spontaneously, more often without or with limited skin changes. The clinical features are very pleomorphic and recognition of the atypical presentations should facilitate the diagnosis. We report a 9-month-old boy who had an extensive, atrophic lesion on the proximal thigh that followed the course of the congenital giant form. The large size of the lesion does not alter the clinical course or result in extracutaneous involvement, which remains rare. However, uncommon clinical presentations raise the problem of differential diagnosis, requiring biopsy to eliminate other tumors with a less favorable prognosis.
Collapse
Affiliation(s)
- A Imiela
- Dermatology Service, Hôpital Claude Huriez, Centre Hospitalier Universitaire de Lille, 59037 Lille Cedex, France.
| | | | | | | | | |
Collapse
|
43
|
Carpentier O, Staumont-Sallé D, Piette F, Delaporte E. Lupus miliaire de la face. Six observations. Rev Med Interne 2003. [DOI: 10.1016/s0248-8663(03)80021-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
44
|
Canonne-Courivaud D, Carpentier O, Dejobert Y, Hachulla E, Delaporte E. [Lichenoid drug reaction to leflunomide]. Ann Dermatol Venereol 2003; 130:435-7. [PMID: 12843855] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 03/03/2023]
Abstract
INTRODUCTION Leflunomide (Arava) is an immunomodulator, recently introduced for systemic treatment of rheumatoid arthritis. We report the first case of lichenoid drug reaction due to this drug. CASE REPORT A sixty-four year-old woman received leflunomide for rheumatoid arthritis. Two months after initiation of treatment, pruritus and lichenoid papules appeared on her hands and subsequently on her arms and her trunk, with a few bullous lesions. A skin biopsy was evocative for the diagnosis of drug induced lichenoid eruption. The treatment was stopped, and a wash out with colestyramine and topical corticotherapy resulted in dramatic improvement. No relapse was observed. Two months later, patch-tests with leflunomide diluted to 30 p. 100 in white petrolatum were negative. DISCUSSION Side effects of leflunomide are frequent, generally benign for the cutaneous features. In our case, the delay, clinical and histological aspect and improvement on withdrawal of the drug emphasize the imputability of leflunomide. Few cases have been reported with others immunomodulators.
Collapse
|
45
|
|
46
|
Affiliation(s)
- C Dupont-Creteur
- Clinique de dermatologie, hôpital Claude-Huriez, CHRU, 59037 Lille, France
| | | | | |
Collapse
|
47
|
Carpentier O, Carrotte-Lefebvre I, Patenotre P, Mirabel X, Delaporte E, Piette F. [Primitive cutaneous neuroendocrine carcinomas or Merkel's tumor. Clinical and therapeutic aspects in 22 patients]. Presse Med 2002; 31:735-9. [PMID: 12148350] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/26/2023] Open
Abstract
INTRODUCTION Primitive cutaneous neuroendocrine carcinoma (PCNC) is a rare tumor with poor prognosis. Surgery is the treatment of choice, but radiotherapy is taking a larger place in the management of these patients. METHODS The files of 22 patients were studied retrospectively over a period of 14 years. RESULTS The study included 17 women and 5 men with a mean age of 75.5 years. The localization of the tumor was the cephalic extremity in 12 cases. At the initial stage, the tumor in 3 of the 22 patients was of glandular or visceral localization. Thirteen stage I patients were treated surgically. Adjuvant radiotherapy was performed in 10 of these patients and only one relapsed (incomplete initial exeresis). The other three relapsed. Exclusive radiotherapy led to complete response in 4 patients who could not undergo surgery and in 2 with local relapses. Seven patients exhibited glandular involvement and 6 of them died (median 7 months) after the adenopathy had been discovered. DISCUSSION Our series illustrates the clinical characteristics of this tumor of the elderly, which is predominantly cephalic and of rapid progression. From a therapeutic point of view, our results underline the benefit of radiotherapy as adjuvant to surgery. When surgery is impossible, and in the case of local relapse, radiotherapy gives good results.
Collapse
Affiliation(s)
- O Carpentier
- Clinique dermatologique, Hôpital Claude-Huriez, 59037 Lille
| | | | | | | | | | | |
Collapse
|
48
|
Carpentier O, Cottencin-Charriere AC, Patenotre P, Piette F. [Tumor of the nose]. Ann Dermatol Venereol 2001; 128:1245-6. [PMID: 11908172] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/24/2023]
|
49
|
Carpentier O, Dubost-Brama A, Martin De Lassalle E, Piette F, Delaporte E. [Rhabdomyosarcoma at site of pacemaker implantation]. Ann Dermatol Venereol 2000; 127:837-40. [PMID: 11060388] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/18/2023]
Abstract
BACKGROUND Malignant proliferation at the site of implantation of a pacemaker generator is uncommon. We report the case of a patient who developed rhabdomyosarcoma. CASE REPORT A 85-year-old man presented with a voluminous and rapidly evolving tumor localised beneath the right clavicle. This inflammatory and necrotic lesion developed on the area where a titanium pacemaker had been implanted five years earlier. Rhabdomyosarcoma was diagnosis on the basis of immunohistochemistry findings. In spite of a wide surgical excision of this primitive tumour, visceral dissemination appeared, rapidly leading to the patient's death. DISCUSSION This observation rises the question of the role of the pacemaker implantation in tumor development. The excellent in vivo tolerance and the widespread utilization of titanium as biomaterial is an argument against its carcinogenic action. Inversely, a metal-related chronic inflammatory reaction could favor the neoplastic process in predisposed subjects as has been observed with prosthetic materials used in orthopaedics.
Collapse
Affiliation(s)
- O Carpentier
- Clinique de Dermatologie, Hôpital Claude-Huriez, 59037 Lille Cedex
| | | | | | | | | |
Collapse
|